본문 바로가기
KERD
논문KCI 등재

Liver sinusoidal endothelial cell: An important yet often overlooked player in the liver fibrosis

Le Wang|Xiaojiaoyang Li|Jiaorong Qu|Yufei Li
대한간학회 (The korean Association for the Study of the Liver)|2024.07|Clinical and Molecular Hepatology|제30권 제3호|pp. 303-325|DOI 10.3350/cmh.2024.0022

2

조회

0

다운로드

2

인용

0

참고문헌

키워드

Liver fibrosisLiver sinusoidal endothelial cellsFenestraeCapillarizationIntercellular communication

초록

Liver sinusoidal endothelial cells (LSECs) are liver-specific endothelial cells with the highest permeability than other mammalian endothelial cells, characterized by the presence of fenestrae on their surface, the absence of diaphragms and the lack of basement membrane. Located at the interface between blood and other liver cell types, LSECs mediate the exchange of substances between the blood and the Disse space, playing a crucial role in maintaining substance circulation and homeostasis of multicellular communication. As the initial responders to chronic liver injury, the abnormal LSEC activation not only changes their own physicochemical properties but also interrupts their communication with hepatic stellate cells and hepatocytes, which collectively aggravates the process of liver fibrosis. In this review, we have comprehensively updated the various pathways by which LSECs were involved in the initiation and aggravation of liver fibrosis, including but not limited to cellular phenotypic change, the induction of capillarization, decreased permeability and regulation of intercellular communications. Additionally, the intervention effects and latest regulatory mechanisms of anti-fibrotic drugs involved in each aspect have been summarized and discussed systematically. As we studied deeper into unraveling the intricate role of LSECs in the pathophysiology of liver fibrosis, we unveil a promising horizon that pave the way for enhanced patient outcomes.

Abstract

Liver sinusoidal endothelial cells (LSECs) are liver-specific endothelial cells with the highest permeability than other mammalian endothelial cells, characterized by the presence of fenestrae on their surface, the absence of diaphragms and the lack of basement membrane. Located at the interface between blood and other liver cell types, LSECs mediate the exchange of substances between the blood and the Disse space, playing a crucial role in maintaining substance circulation and homeostasis of multicellular communication. As the initial responders to chronic liver injury, the abnormal LSEC activation not only changes their own physicochemical properties but also interrupts their communication with hepatic stellate cells and hepatocytes, which collectively aggravates the process of liver fibrosis. In this review, we have comprehensively updated the various pathways by which LSECs were involved in the initiation and aggravation of liver fibrosis, including but not limited to cellular phenotypic change, the induction of capillarization, decreased permeability and regulation of intercellular communications. Additionally, the intervention effects and latest regulatory mechanisms of anti-fibrotic drugs involved in each aspect have been summarized and discussed systematically. As we studied deeper into unraveling the intricate role of LSECs in the pathophysiology of liver fibrosis, we unveil a promising horizon that pave the way for enhanced patient outcomes.

참고문헌 (115)

  1. Parola M, "Liver fibrosis : Pathophysiology, pathogenetic targets and clinical issues", Mol Aspects Med, 65, pp.37~55 (2019)
  2. Zhang D, "The Molecular mechanisms of liver fibrosis and its potential therapy in application", Int J Mol Sci, 23, pp.12572~ (2022)
  3. Pinheiro D, "Mechanisms underlying cell therapy in liver fibrosis : An overview", Cells, 8, pp.1339~ (2019)
  4. Hammerich L, "Hepatic inflammatory responses in liver fibrosis", Nat Rev Gastroenterol Hepatol, 20, pp.633~646 (2023)
  5. Kisseleva T, "Molecular and cellular mechanisms of liver fibrosis and its regression", Nat Rev Gastroenterol Hepatol, 18, pp.151~166 (2021)
  6. Shetty S, "Liver sinusoidal endothelial cells-gatekeepers of hepatic immunity", Nat Rev Gastroenterol Hepatol, 15, pp.555~567 (2018)
  7. Gracia-Sancho J, "Role of liver sinusoidal endothelial cells in liver diseases", Nat Rev Gastroenterol Hepatol, 18, pp.411~431 (2021)
  8. Poisson J, "Liver sinusoidal endothelial cells : Physiology and role in liver diseases", J Hepatol, 66, pp.212~227 (2017)
  9. Ishikawa T, "Fc gamma RIIb expression levels in human liver sinusoidal endothelial cells during progression of non-alcoholic fatty liver disease", PLoS One, 14, pp.e0211543~ (2019)
  10. Yang M, "The role of liver sinusoidal endothelial cells in cancer liver metastasis", Am J Cancer Res, 11, pp.1845~1860 (2021)
  11. Marrone G, "Sinusoidal communication in liver fibrosis and regeneration", J Hepatol, 65, pp.608~617 (2016)
  12. Cheng QN, "Interaction of non‑parenchymal hepatocytes in the process of hepatic fibrosis(Review)", Mol Med Rep, 23, pp.364~ (2021)
  13. Tsuchida T, "Mechanisms of hepatic stellate cell activation", Nat Rev Gastroenterol Hepatol, 14, pp.397~411 (2017)
  14. Hwang JH, "Endothelial TAZ inhibits capillarization of liver sinusoidal endothelium and damage-induced liver fibrosis via nitric oxide production", Theranostics, 13, pp.4182~4196 (2023)
  15. Lafoz E, "The endothelium as a driver of liver fibrosis and regeneration", Cells, 9, pp.929~ (2020)
  16. Li G, "Curcumol may reverse early and advanced liver fibrogenesis through downregulating the uPA", uPAR pathway, 2020, pp.34, 1421~1435
  17. Li F, "Restoration of sinusoid fenestrae followed by targeted nanoassembly delivery of an anti-fibrotic agent improves treatment efficacy in liver fibrosis", Adv Mater, 35, pp.e2212206~ (2023)
  18. Zhou D, "Trimethylamine-Noxide(TMAO)mediates the crosstalk between the gut microbiota and hepatic vascular niche to alleviate liver fibrosis in nonalcoholic steatohepatitis", Front Immunol, 13, pp.964477~ (2022)
  19. Pegoraro AF, "Mechanical properties of the cytoskeleton and cells", Cold Spring Harb Perspect Biol, 9, pp.a022038~ (2017)
  20. Qu J, "Si-Wu-Tang attenuates liver fibrosis via regulating lncRNA H19-dependent pathways involving cytoskeleton remodeling and ECM deposition", Chin J Nat Med, 22, pp.31~46 (2024)
  21. Desroches-Castan A, "Bone morphogenetic protein 9 is a paracrine factor controlling liver sinusoidal endothelial cell fenestration and protecting against hepatic fibrosis", Hepatology, 70, pp.1392~1408 (2019)
  22. Desroches-Castan A, "Differential consequences of Bmp9 deletion on sinusoidal endothelial cell differentiation and liver fibrosis in 129", Ola and C57BL, Cells, pp.2019, 8[DOI]
  23. Di Martino J, "Actin depolymerization in dedifferentiated liver sinusoidal endothelial cells promotes fenestrae reformation", Hepatol Commun, 3, pp.213~219 (2018)
  24. Qu J, "The tumor-enriched small molecule gambogic amide suppresses glioma by targeting WDR1-dependent cytoskeleton remodeling", Signal Transduct Target Ther, 8, pp.424~ (2023)
  25. Luo X, "Sirtuin 1ameliorates defenestration in hepatic sinusoidal endothelial cells during liver fibrosis via inhibiting stress-induced premature senescence", Cell Prolif, 54, pp.e12991~ (2021)
  26. Yang L, "Vascular endothelial growth factor promotes fibrosis resolution and repair in mice", Gastroenterology, 146, pp.1339~1350 (2014)
  27. Yuan K, "The effect of vascular endothelial growth factor on bone marrow mesenchymal stem cell engraftment in rat fibrotic liver upon transplantation", Stem Cells Int, 2019, pp.5310202~ (2019)
  28. DeLeve LD, "Liver sinusoidal endothelial cells in hepatic fibrosis", Hepatology, 61, pp.1740~1746 (2015)
  29. Baiocchini A, "Liver sinusoidal endothelial cells(LSECs)modifications in patients with chronic hepatitis C", Sci Rep, 9, pp.8760~ (2019)
  30. Maretti-Mira AC, "Incomplete differentiation of engrafted bone marrow endothelial progenitor cells initiates hepatic fibrosis in the rat", Hepatology, 69, pp.1259~1272 (2019)
  31. Duan JL, "Agerelated liver endothelial zonation triggers steatohepatitis by inactivating pericentral endothelium-derived C-kit", Nat Aging, 3, pp.258~274 (2023)
  32. Huang R, "Sulodexide attenuates liver fibrosis in mice by restoration of differentiated liver sinusoidal endothelial cell", Biomed Pharmacother, 160, pp.114396~ (2023)
  33. Bae CR, "The endothelial dysfunction blocker CU06-1004 ameliorates choline-deficient L-amino acid diet-induced non-alcoholic steatohepatitis in mice", PLoS One, 15, pp.e0243497~ (2020)
  34. Wu Y, "Carvedilol attenuates carbon tetrachloride-induced liver fibrosis and hepatic sinusoidal capillarization in mice", Drug Des Devel Ther, 13, pp.2667~2676 (2019)
  35. Wang L, "Neuropilin-1aggravates liver cirrhosis by promoting angiogenesis via VEGFR2-dependent PI3K", Akt pathway in hepatic sinusoidal endothelial cells, 2019, pp.43, 525~536
  36. Li G, "Plumbagin alleviates capillarization of hepatic sinusoids in vitro by downregulating ET-1, VEGF, LN, and type IV collagen", Biomed Res Int, 2017, pp.5603216~ (2017)
  37. Zhao S, "Tetramethylpyrazine attenuates carbon tetrachloride-caused liver injury and fibrogenesis and reduces hepatic angiogenesis in rats", Biomed Pharmacother, 86, pp.521~530 (2017)
  38. Zhao ZM, "Levistilide A inhibits angiogenesis in liver fibrosis via vascular endothelial growth factor signaling pathway", Exp Biol Med(Maywood), 242, pp.974~985 (2017)
  39. You Q, "Human recombinant endostatin Endostar attenuates hepatic sinusoidal endothelial cell capillarization in CCl4‑induced fibrosis in mice", Mol Med Rep, 12, pp.5594~5600 (2015)
  40. Kong LJ, "Vatalanib, a tyrosine kinase inhibitor, decreases hepatic fibrosis and sinusoidal capillarization in CCl4-induced fibrotic mice", Mol Med Rep, 15, pp.2604~2610 (2017)
  41. Ogawa H, "Lenvatinib prevents liver fibrosis by inhibiting hepatic stellate cell activation and sinusoidal capillarization in experimental liver fibrosis", J Cell Mol Med, 25, pp.4001~4013 (2021)
  42. Wu Y, "Olmesartan Improves Hepatic Sinusoidal Remodeling in Mice with Carbon Tetrachloride-Induced Liver Fibrosis", Biomed Res Int, 2022, pp.4710993~ (2022)
  43. Wang Q, "microRNA-322", 424 promotes liver fibrosis by regulating angiogenesis through targeting CUL2, Life Sci, pp.2021, 266[DOI]
  44. Liu HL, "Fuzhenghuayu Decoction ameliorates hepatic fibrosis by attenuating experimental sinusoidal capillarization and liver angiogenesis", Sci Rep, 9, pp.18719~ (2019)
  45. Zhou YN, "Xuefuzhuyu decoction inhibition of angiogenesis attenuates liver fibrosis induced by CCl₄ in mice", J Ethnopharmacol, 153, pp.659~666 (2014)
  46. Xue X, "Carthami flos extract against carbon tetrachloride-induced liver fibrosis via alleviating angiogenesis in mice", Phytomedicine, 108, pp.154517~ (2023)
  47. Zhang C, "Oroxylin A prevents angiogenesis of LSECs in liver fibrosis via inhibition of YAP", HIF-1α signaling, 2018, pp.119, 2258~2268
  48. Yang X, "Curcumol attenuates liver sinusoidal endothelial cell angiogenesis via regulating Glis-PROX1-HIF-1α in liver fibrosis", Cell Prolif, 53, pp.e12762~ (2020)
  49. Zhao S, "Tetramethylpyrazine attenuates sinusoidal angiogenesis via inhibition of hedgehog signaling in liver fibrosis", IUBMB Life, 69, pp.115~127 (2017)
  50. Xing Y, "Liver X receptor α is essential for the capillarization of liver sinusoidal endothelial cells in liver injury", Sci Rep, 6, pp.21309~ (2016)
  51. Lee HS, "Altered AKAP12 expression in portal fibroblasts and liver sinusoids mediates transition from hepatic fibrogenesis to fibrosis resolution", Exp Mol Med, 50, pp.1~13 (2018)
  52. Chen L, "Delta-like ligand 4", DLL4 regulates the capillarization of liver sinusoidal endothelial cell and liver fibrogenesis, 2019, pp.1866, 1663~1675
  53. Gu T, "miR-30c inhibits angiogenesis by targeting delta-like ligand 4 in liver sinusoidal endothelial cell to attenuate liver fibrosis", FASEB J, 35, pp.e21571~ (2021)
  54. Xu M, "LECT2, a ligand for Tie1, plays a crucial role in liver fibrogenesis", Cell, 178, pp.1478~1492 (2019)
  55. Li N, "Multiscale biomechanics and mechanotransduction from liver fibrosis to cancer", Adv Drug Deliv Rev, 188, pp.114448~ (2022)
  56. Gao L, "Curcumol inhibits KLF5-dependent angiogenesis by blocking the ROS", ERK signaling in liver sinusoidal endothelial cells, 2021, pp.264, 118696~
  57. Gao L, "Autophagy-induced p62 accumulation is required for curcumol to regulate KLF5-mediated angiogenesis in liver sinusoidal endothelial cells", Toxicology, 452, pp.152707~ (2021)
  58. Li Y, "Blockade of KLF5", LDH-A feedback loop contributes to Curcumol inhibition of sinusoidal endothelial cell glycolysis and mitigation of liver fibrosis, 2023, pp.114, 154759~
  59. Yu Z, "Nano delivery of simvastatin targets liver sinusoidal endothelial cells to remodel tumor microenvironment for hepatocellular carcinoma", J Nanobiotechnology, 20, pp.9~ (2022)
  60. Brougham-Cook A, "Engineered matrix microenvironments reveal the heterogeneity of liver sinusoidal endothelial cell phenotypic responses", APL Bioeng, 6, pp.046102~ (2022)
  61. Boyer-Diaz Z, "Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental advanced chronic liver disease", J Hepatol, 74, pp.1188~1199 (2021)
  62. Ruan B, "Capillarized liver sinusoidal endothelial cells undergo partial endothelial-mesenchymal transition to actively deposit sinusoidal ECM in liver fibrosis", Front Cell Dev Biol, 9, pp.671081~ (2021)
  63. Hammoutene A, "A defect in endothelial autophagy occurs in patients with non-alcoholic steatohepatitis and promotes inflammation and fibrosis", J Hepatol, 72, pp.528~538 (2020)
  64. Li Z, "MKL1promotes endothelial-to-mesenchymal transition and liver fibrosis by activating TWIST1 transcription", Cell Death Dis, 10, pp.899~ (2019)
  65. Li Z, "The chromatin remodeler Brg1 integrates ROS production and endothelial-mesenchymal transition to promote liver fibrosis in mice", Front Cell Dev Biol, 7, pp.245~ (2019)
  66. Wei M, "HMGB1 induced endothelial to mesenchymal transition in liver fibrosis : The key regulation of early growth response factor 1", Biochim Biophys Acta Gen Subj, 1866, pp.130202~ (2022)
  67. Miao H, "Chlorogenic acid alleviated liver fibrosis in methionine and choline deficient diet-induced nonalcoholic steatohepatitis in mice and its mechanism", J Nutr Biochem, 106, pp.109020~ (2022)
  68. Rafii S, "Angiocrine functions of organspecific endothelial cells. Nature 2016;529 : 316-325. 69 Ding BS, Cao Z, Lis R, Nolan DJ, Guo P, Simons M, et al. Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis", Nature, 505, pp.97~102 (2014)
  69. Huebert RC, "Sinusoidal endothelial cells direct traffic at the intersection of regeneration and fibrosis", Hepatology, 60, pp.754~756 (2014)
  70. Greuter T, "Mechanotransduction-induced glycolysis epigenetically regulates a CXCL1-dominant angiocrine signaling program in liver sinusoidal endothelial cells in vitro and in vivo", J Hepatol, 77, pp.723~734 (2022)
  71. Delgado I, "GATA4 loss in the septum transversum mesenchyme promotes liver fibrosis in mice", Hepatology, 59, pp.2358~2370 (2014)
  72. Winkler M, "Endothelial GATA4 controls liver fibrosis and regeneration by preventing a pathogenic switch in angiocrine signaling", J Hepatol, 74, pp.380~393 (2021)
  73. Gao J, "Endothelial p300 promotes portal hypertension and hepatic fibrosis through C-C motif chemokine ligand 2-mediated angiocrine signaling", Hepatology, 73, pp.2468~2483 (2021)
  74. Duan JL, "Endothelial Notch activation reshapes the angiocrine of sinusoidal endothelia to aggravate liver fibrosis and blunt regeneration in mice", Hepatology, 68, pp.677~690 (2018)
  75. Shao J, "BRG1 deficiency in endothelial cells alleviates thioacetamide induced liver fibrosis in mice", Biochem Biophys Res Commun, 521, pp.212~219 (2020)
  76. Jiang T, "Pathological changes in hepatic sinusoidal endothelial cells in Schistosoma japonicum-infected mice", Trop Med Infect Dis, 8, pp.124~ (2023)
  77. Yamauchi A, "Placental extract ameliorates non-alcoholic steatohepatitis(NASH)by exerting protective effects on endothelial cells", Heliyon, 3, pp.e00416~ (2017)
  78. Gracia-Sancho J, "Emricasan ameliorates portal hypertension and liver fibrosis in cirrhotic rats through a hepatocyte-mediated paracrine mechanism", Hepatol Commun, 3, pp.987~1000 (2019)
  79. Di Pascoli M, "Resveratrol improves intrahepatic endothelial dysfunction and reduces hepatic fibrosis and portal pressure in cirrhotic rats", J Hepatol, 58, pp.904~910 (2013)
  80. Lao Y, "Targeting endothelial Erk1", 2-Akt axis as a regeneration strategy to bypass fibrosis during chronic liver injury in mice, 2018, pp.26, 2779~2797
  81. Zheng Y, "Modulation of the VEGF", AKT, J Ethnopharmacol, pp.2021, 280[DOI]
  82. Ruart M, "Impaired endothelial autophagy promotes liver fibrosis by aggravating the oxidative stress response during acute liver injury", J Hepatol, 70, pp.458~469 (2019)
  83. Li Y, "Self-eating : friend or foe? The emerging role of autophagy in fibrotic diseases", Theranostics, 10, pp.7993~8017 (2020)
  84. Luo X, "Autophagic degradation of caveolin-1 promotes liver sinusoidal endothelial cells defenestration", Cell Death Dis, 9, pp.576~ (2018)
  85. Ring A, "The hepatic microvascular responses to sepsis", Semin Thromb Hemost, 26, pp.589~594 (2000)
  86. Colucci S, "Liver sinusoidal endothelial cells suppress bone morphogenetic protein 2 production in response to TGFβ pathway activation", Hepatology, 74, pp.2186~2200 (2021)
  87. Piao J, "Substance P promotes liver sinusoidal endothelium-mediated hepatic regeneration by NO", HGF regulation, 2019, pp.39, 147~154
  88. Yan Z, "CD147promotes liver fibrosis progression via VEGF-A", VEGFR2signalling-mediated cross-talk between hepatocytes and sinusoidal endothelial cells, 2015, pp.129, 699~710
  89. Yagai T, "Semaphorin 3E secreted by damaged hepatocytes regulates the sinusoidal regeneration and liver fibrosis during liver regeneration", Am J Pathol, 184, pp.2250~2259 (2014)
  90. Jia K, "Acteoside ameliorates hepatic ischemia-reperfusion injury via reversing the senescent fate of liver sinusoidal endothelial cells and restoring compromised sinusoidal networks", Int J Biol Sci, 19, pp.4967~4988 (2023)
  91. Wu X, "Adipocyte fatty acid binding protein promotes the onset and progression of liver fibrosis via mediating the crosstalk between liver sinusoidal endothelial cells and hepatic stellate cells", Adv Sci(Weinh), 8, pp.e2003721~ (2021)
  92. Fang J, "PDGF-BB is involved in HIF-1α", CXCR4, Heliyon, pp.2022, 9[DOI]
  93. de Haan W, "Endothelial Zeb2 preserves the hepatic angioarchitecture and protects against liver fibrosis", Cardiovasc Res, 118, pp.1262~1275 (2022)
  94. Chen T, "LncRNA Airn maintains LSEC differentiation to alleviate liver fibrosis via the KLF2-eNOS-sGC pathway", BMC Med, 20, pp.335~ (2022)
  95. Liu L, "Mechanotransduction-modulated fibrotic microniches reveal the contribution of angiogenesis in liver fibrosis", Nat Mater, 16, pp.1252~1261 (2017)
  96. Chen T, "Autophagic degradation of MVBs in LSECs promotes Aldosterone induced-HSCs activation", Hepatol Int, 18, pp.273~288 (2024)
  97. Liao Y, "Liver sinusoidal endothelial S1pr2 regulates experimental liver fibrosis through YAP", TGF-β signaling pathway, 2023, pp.37, e22905~
  98. Guo Q, "Liver sinusoidal endothelial cell expressed vascular cell adhesion molecule 1 promotes liver fibrosis", Front Immunol, 13, pp.983255~ (2022)
  99. Ye Q, "Salidroside inhibits CCl4-induced liver fibrosis in mice by reducing activation and migration of HSC induced by liver sinusoidal endothelial cellderived exosomal SphK1", Front Pharmacol, 12, pp.677810~ (2021)
  100. Chen HJ, "Scutellariae radix suppresses LPS-induced liver endothelial cell activation and inhibits hepatic stellate cell migration", J Ethnopharmacol, 150, pp.835~842 (2013)
  101. Brozat JF, "JAM-A is a multifaceted regulator in hepatic fibrogenesis, supporting LSEC integrity and stellate cell quiescence", Liver Int, 42, pp.1185~1203 (2022)
  102. Hintermann E, "Murine junctional adhesion molecules JAM-B and JAM-C mediate endothelial and stellate cell interactions during hepatic fibrosis", Cell Adh Migr, 10, pp.419~433 (2016)
  103. Kawashita E, "Endothelial group IVA phospholipase A2 promotes hepatic fibrosis with sinusoidal capillarization in the early stage of nonalcoholic steatohepatitis in mice", Life Sci, 294, pp.120355~ (2022)
  104. Zhong Y, "Inhibiting Th1", 2 cells influences hepatic capillarization by adjusting sinusoidal endothelial fenestrae through Rho-ROCK-myosin pathway, 2021, pp.13, 5069~5086
  105. Sakai M, "Liver-derived signals sequentially reprogram myeloid enhancers to initiate and maintain kupffer cell identity", Immunity, 51, pp.655~670 (2019)
  106. Kohara S, "Eph", Ephrin promotes the adhesion of liver tissue-resident macrophages to a mimicked surface of liver sinusoidal endothelial cells, 2022, pp.10, 3234~
  107. Ford AJ, "Designing a fibrotic microenvironment to investigate changes in human liver sinusoidal endothelial cell function", Acta Biomater, 24, pp.220~227 (2015)
  108. Bale SS, "Isolation and co-culture of rat parenchymal and non-parenchymal liver cells to evaluate cellular interactions and response", Sci Rep, 6, pp.25329~ (2016)
  109. Hammoutene A, "Role of liver sinusoidal endothelial cells in non-alcoholic fatty liver disease", J Hepatol, 70, pp.1278~1291 (2019)
  110. Rowe IA, "Paracrine signals from liver sinusoidal endothelium regulate hepatitis C virus replication", Hepatology, 59, pp.375~384 (2014)
  111. Hu J, "Endothelial cell-derived angiopoietin-2 controls liver regeneration as a spatiotemporal rheostat", Science, 343, pp.416~419 (2014)
  112. Finch NC, "The unique structural and functional characteristics of glomerular endothelial cell fenestrations and their potential as a therapeutic target in kidney disease", Am J Physiol Renal Physiol, 325, pp.F465~F478 (2023)
  113. Zapotoczny B, "Actin-spectrin scaffold supports open fenestrae in liver sinusoidal endothelial cells", Traffic, 20, pp.932~942 (2019)
  114. Lin Y, "A strategy of vascular-targeted therapy for liver fibrosis", Hepatology, 76, pp.660~675 (2022)
  115. Zhou F, "Inhibiting autophagy to boost antitumor immunity with tetramethylpyrazineloaded and PD-L1-targeting liposomal nanoparticles", Eur J Pharm Sci, 190, pp.106581~ (2023)

관련 논문AI추천

Sinusoidal communication in chronic liver diseaseAlbert Gibert-Ramos, Jordi Gracia-Sancho, María Andrés-Rozas, Pablo Alfaro-Retamero, Raül Pastó, Sergi Guixé-Muntet대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제1호Unlocking the role of liver sinusoidal endothelial cells: Key players in liver fibrosis: Editorial on “Liver sinusoidal endothelial cell: An important yet often overlooked player in the liver fibrosis”Yasuko Iwakiri대한간학회 · Clinical and Molecular Hepatology2024 · 제30권 제4호Anti-fibrotic treatments for chronic liver diseases: The present and the futureHideki Fujii, Masaru Enomoto, Misako Sato-Matsubara, Naoshi Odagiri, Norifumi Kawada, Tsutomu Matsubara대한간학회 · Clinical and Molecular Hepatology2021 · 제27권 제3호Correspondence to editorial on “Liver sinusoidal endothelial cell: An important yet often overlooked player in the liver fibrosis”Jiaorong Qu, Le Wang, Xiaojiaoyang Li대한간학회 · Clinical and Molecular Hepatology2024 · 제30권 제4호The emerging roles of extracellular vesicles as intercellular messengers in liver physiology and pathologyJong-Hoon Kim, Youngseok Lee대한간학회 · Clinical and Molecular Hepatology2022 · 제28권 제4호Reversal of liver cirrhosis: current evidence and expectations임형준, 정영걸대한내과학회 · The Korean Journal of Internal Medicine2017 · 제32권 제2호

이 간행물의 다른 논문 (18건)

Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradicationChung-Feng Huang, Ming-Lung Yu, Meital Gal-Tanamy, Manar Hijaze Awadpp. 326-344Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: A real-world study김범경, 하연정, 안상훈, 박준용, 전영은, Mi Na Kim, 김승업, Dong Yun Kim, Beodeul Kang, Joo Ho Lee, 김도영, 전홍재, Jung Sun Kim, Kwan Sik Leepp. 345-359Multiomics profiling of buffy coat and plasma unveils etiology-specific signatures in hepatocellular carcinomaSu Bin Lim, Jiwon Hong, Seryoung Park, Soon Sun Kim, Jung Woo Eun, Jae Youn Cheong, Geum Ok Baek, Hyo Jung Chopp. 360-374Phase 1 trial of the safety, pharmacokinetics, and antiviral activity of EDP-514 in untreated viremic chronic hepatitis B patientsGuy De La Rosa, Chi-Yi Chen, Cheng-Yuan Peng, Wan-Long Chuang, Yao-Chun Hsu, Ting-Tsung Chang, Wei-Wen Su, Man-Fung Yuen, Wen-Juei Jeng, Alaa Ahmad, Ed Luo, Annie L. Conerypp. 375-387Dynamic analysis of acute deterioration in chronic liver disease patients using modified quick sequential organ failure assessment정승원, APASL ACLF Research Consortium (AARC) for APASL ACLF Working Party, Vinod Arora, Ashok Kumar Choudhury, 유정주, 김원, Do Seon Song, Ki Tae Suk, Sang Gyune Kim, Young Chang, Hee Yeon Kim, Shiv Kumar Sarin, Young Kul Jung, Jung Gil Park, Sung-Eun Kim, Eileen L. Yoon, 김정희, Dong Joon Kim, Moon Young Kim, Tae Hyung Kim, Jae Young Jang, 임형준pp. 388-405
원문 보기